The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?
Abstract
While it has long been thought that most of cerebral creatine is of peripheral origin, the last 20 years has provided evidence that the creatine synthetic pathway (AGAT and GAMT enzymes) is expressed in the brain together with the creatine transporter (SLC6A8). It has also been shown that SLC6A8 is expressed by microcapillary endothelial cells at the blood-brain barrier, but is absent from surrounding astrocytes, raising the concept that the blood-brain barrier has a limited permeability for peripheral creatine. The first creatine deficiency syndrome in humans was also discovered 20 years ago (GAMT deficiency), followed later by AGAT and SLC6A8 deficiencies, all three diseases being characterized by creatine deficiency in the CNS and essentially affecting the brain. By reviewing the numerous and latest experimental studies addressing creatine transport and synthesis in the CNS, as well as the clinical and biochemical characteristics of creatine-deficient patients, our aim was to delineate a clearer view of the roles of the blood-brain and blood-cerebrospinal fluid barriers in the transport of creatine and guanidinoacetate between periphery and CNS, and on the intracerebral synthesis and transport of creatine. This review also addresses the question of guanidinoacetate toxicity for brain cells, as probably found under GAMT deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some individuals have been found to have creatine synthesis deficiencies due to inborn errors in AGAT, GMAT and/or creatine transporter (CRTR) deficiencies and therefore must depend on dietary creatine intake in order to maintain normal muscle and brain concentrations of PCr and Cr”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [19]
In the citing paper
“clinical populations may need to consume 10–30 g/day throughout their lifespan to offset creatine synthesis deficiencies and/or provide therapeutic benefit in various disease states”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [19]
In the citing paper
“However, higher levels of creatine supplementation for longer periods of time may be needed to increase brain concentrations of creatine, offset creatine synthesis deficiencies, or influence disease states”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [19]
In the citing paper
“Dietary supplementation of 20–30 g/day of creatine monohydrate for up to 5 years has also been studied in some clinical populations who need higher levels to increase brain concentrations of creatine, offset creatine synthesis deficiencies, or influence disease states [51,52,53].”
From Creatine in health and disease (2021) · cites this paper as [52]
In the citing paper
“some of the dietary creatine and creatine synthesized in the liver enters the brain via the SLC6A8 Cr transporter (CT1), which is expressed in the microcapillaries of the BBB, neurons, and oligodendrocytes [241]”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [241]
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Mitochondrial creatine kinase in human health and disease
Schlattner, U., Tokarska-Schlattner, M., & Wallimann, T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.09.004 · Cited by 622
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417 · cited 5×
“…with high Cr doses slowly replenishes their brain Cr pool, demonstrating that it can nevertheless be taken up from the periphery into the CNS through the SLC6A8 transporter expressed on MCEC at the BBB (Stöckler et al. 1994; Schulze et al. 1997; Braissant 2014; Stöckler-Ipsiroglu et al. 2014).”
InfluentialChen, N.-H., Reith, M. E. A., & Quick, M. W. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1064-5 · Cited by 409
X-Linked Creatine-Transporter Gene (SLC6A8) Defect: A New Creatine-Deficiency Syndrome
Salomons, G. S., van Dooren, S. J. M., Verhoeven, N. M., Cecil, K. M., Ball, W. S., Degrauw, T. J., & Jakobs, C. (2001) · The American Journal of Human Genetics · doi:10.1086/320595 · Cited by 396
Creatine kinase in non-muscle tissues and cells
Wallimann, T., & Hemmer, W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf01267955 · Cited by 374
Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
Braissant, O., McLin, V. A., & Cudalbu, C. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9546-2 · Cited by 287
Self-citation
Research works printed but not linked: 3
- Craigen WJ, Stromberger C, Donti T, Raghavan A, Ather S, Wehrens X, Akman HO (2011) A mouse model of creatine deficiency due to targeted disruption of Alanine: glycine Amidinotransferase exhibits muscle hypoplasia, mitochondrial dysfunction, and weakness. J Inherit Metab Dis 34:125
- Sinha A, Ahmed S, von Both I, Isbrandt D, Henkelman R, Schulze A (2011) Anatomical phenotyping in mouse models of AGAT and GAMT deficiency with magnetic resonance imaging. J Inherit Metab Dis 34:124
- Wilcken B, Fagan E, Sim K, Carpenter KH, Salomons GS (2008) Creatine transporter defect: results of 6 months’ treatment. J Inherit MetabDis 31(Suppl):70
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“However, higher levels of creatine supplementation for longer periods of time may be needed to increase brain concentrations of creatine, offset creatine synthesis deficiencies, or influence disease states [13, 19, 23].”
BackgroundOxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review
Bonilla, D. A., Kreider, R. B., Stout, J. R., Forero, D. A., Kerksick, C. M., Roberts, M. D., & Rawson, E. S. (2021) · Nutrients · doi:10.3390/nu13041238 · Cited by 223
“Cr is one of the main osmolytes of the central nervous system, which may play important roles in pathophysiological conditions of the brain [18,19].”
BackgroundSchlattner, U., Klaus, A., Ramirez Rios, S., Guzun, R., Kay, L., & Tokarska-Schlattner, M. (2016) · Amino Acids · doi:10.1007/s00726-016-2267-3 · Cited by 96
Metadata
- Authors
- Hanna-El-Daher, L., & Braissant, O.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Braissant, Olivier
- ORCID
- Braissant, Olivier
- Venue
- Amino Acids
- Published
- 2016-02-10
- Volume
- 48
- Issue
- 8
- Pages
- 1877-1895
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- OpenAlex
- W2264834965
- Cited by
- 65
- References
- 129
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 13 · 2020: 1 · 2019: 8 · 2018: 4 · 2017: 6 · 2016: 6
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Amino Acids (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A-130278, 3100A0-116859)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- creatine synthesis, creatine deficiency syndrome, GAMT deficiency, SLC6A8, creatine transporter, blood-brain barrier, blood-CSF barrier, guanidinoacetic acid, astrocytes
- MeSH terms
- Amidinotransferases, Amino Acid Metabolism, Inborn Errors, Animals, Blood-Brain Barrier, Capillaries, Developmental Disabilities, Creatine, Disease Models, Animal, Humans, Language Development Disorders, Intellectual Disability, Movement Disorders, Nerve Tissue Proteins, Speech Disorders, Brain Diseases, Metabolic, Inborn, X-Linked Intellectual Disability, Endothelial Cells, Plasma Membrane Neurotransmitter Transport Proteins, Guanidinoacetate N-Methyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models? https://app.cochat.ai/papers/10.1007/s00726-016-2189-0
- The paper
- Hanna-El-Daher, L., & Braissant, O. (2016). Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models? Amino Acids. https://doi.org/10.1007/s00726-016-2189-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.